Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Morphotek (United States) | Researchclopedia

Back to institutions

Morphotek (United States)

Exton, Pennsylvaniacompany

115

Works

16,465

Citations

65

h-index

Top Research Topics

Monoclonal and Polyclonal Antibodies Research Cancer Research and Treatments Ovarian cancer diagnosis and treatment

Top Researchers

Julie R. Brahmer Bloomberg (United States)

822 works122,687 citationsh-index: 115

Recent Research

Abstract 2370: Synergistic effect of carboplatin on farletuzumab (FAR) tumor cell killing via downregulation of the humoral immunosuppressive CA125 protein and enhanced antibody dependent cellular cytotoxicity (ADCC)

Jake Kline,Keiji Furuuchi,et al.

20191 citations

Cancer-related Molecular Pathways

HER2/EGFR in Cancer Research

Occupational and environmental lung diseases

Cell Adhesion Molecules Research

Glycosylation and Glycoproteins Research

Galectins and Cancer Biology

Lung Cancer Treatments and Mutations

Angiogenesis and VEGF in Cancer

Pleural and Pulmonary Diseases

Ira Pastan National Institutes of Health

1,616 works108,351 citationsh-index: 164

Yuichi Sugiyama Yokohama City University Medical Center

1,121 works50,823 citationsh-index: 112

Daniel A. Laheru Johns Hopkins University

635 works36,125 citationsh-index: 77

Carol Aghajanian Memorial Sloan Kettering Cancer Center

828 works35,718 citationsh-index: 88

Young Joo Park Seoul National University of Science and Technology

1,481 works21,203 citationsh-index: 74

Abstract 2370: Synergistic effect of carboplatin on farletuzumab (FAR) tumor cell killing via downregulation of the humoral immunosuppressive CA125 protein and enhanced antibody dependent cellular cytotoxicity (ADCC)

J. Bradford Kline,Keiji Furuuchi,et al.

20191 citations

Specific loss of adipocyte CD248 improves metabolic health via reduced white adipose tissue hypoxia, fibrosis and inflammation

Paul Petrus,Tara L. Fernandez,et al.

201941 citations

A phase 1 and randomized controlled phase 2 trial of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb‐004) in metastatic soft‐tissue sarcomas

Robin L. Jones,Sant P. Chawla,et al.

201926 citations

MORAb-202, an Antibody–Drug Conjugate Utilizing Humanized Anti-human FRα Farletuzumab and the Microtubule-targeting Agent Eribulin, has Potent Antitumor Activity

Xin Cheng,Jing Li,et al.

201891 citations

Tumor‐shed antigen CA125 blocks complement‐mediated killing via suppression of C1q‐antibody binding

J. Bradford Kline,Shawn Fernando,et al.

20188 citations